Medidata Solutions (MDSO) Tops Q2 EPS by 3c; Guides

Medidata Solutions (NASDAQ: MDSO) reported Q2 EPS of $0.31, $0.03 better than the analyst estimate of $0.28. Revenue for the quarter came in at $137.4 million versus the consensus estimate of $134.26 million.

"As our second quarter and first half year results show, our investments in innovation and talent are paying off, creating value and establishing Medidata as the trusted partner of choice for life sciences," said Tarek Sherif, Medidata's chairman and chief executive officer. "Clinical research continues to grow more complex, and our ability to deliver the leading end-to-end cloud platform, apply advanced analytics and augment this technology with our deep life sciences expertise, empowers our customers to meet this challenge, pursue opportunities, and ultimately improve patient outcomes."

GUIDANCE:

Medidata Solutions sees FY2017 revenue of $538-562 million, versus the consensus of $552.78 million.

For earnings history and earnings-related data on Medidata Solutions (MDSO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral